Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,552 transcripts · 1,674 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 78 of 296 · 3,552 calls

  • Cerence (CRNC) Q3 2026 earnings call

    Management framed Q3 as execution against its turnaround, with XUI moving into commercialization and non-automotive activity beginning to convert toward revenue.

    Aug 06, 2026Confident0.72
  • Arteris (AIP) Q2 2026 earnings call

    Management framed demand as broadening beyond AI infrastructure, while raising revenue guidance despite payroll taxes and lower-margin security government work.

    Aug 06, 2026Confident0.82
  • Akamai Technologies (AKAM) Q2 2026 earnings call

    Management framed AI demand as accelerating Akamai’s cloud and security opportunities, with large contracts supporting a sharper growth outlook beyond this year.

    Aug 06, 2026Confident0.72
  • Alarm.com Holdings (ALRM) Q2 2026 earnings call

    Management framed broad-based growth initiatives, commercial expansion and Energy Hub momentum as supporting raised full-year expectations.

    Aug 06, 2026Confident0.87
  • Artivion (AORT) Q2 2026 earnings call

    Management framed the quarter as restored execution, with AMDS approval and Nexus integration improving confidence while preserving conservative 2026 assumptions.

    Aug 06, 2026Confident0.82
  • Arrow Electronics (ARW) Q2 2026 earnings call

    Management framed the quarter as a broad-based, demand-led recovery with improving visibility, better growth quality and further operating leverage.

    Aug 06, 2026Confident0.78
  • Better Home & Finance Holding (BETR) Q2 2026 earnings call

    The call framed the leadership transition as a shift from founder-led breadth to focused enterprise execution, while resetting profitability timing around execution and partner launches.

    Aug 06, 2026Cautious-0.20
  • Blend Labs (BLND) Q2 2026 earnings call

    Management framed AI commercialization and internal agent adoption as long-term growth levers despite mortgage-rate pressure delaying near-term volume recovery.

    Aug 06, 2026Confident0.78
  • Biomarin Pharmaceutical (BMRN) Q2 2026 earnings call

    Management framed Amicus as exceeding integration expectations while competitive pressure on Voxzogo remains manageable and pipeline execution accelerates.

    Aug 06, 2026Confident0.84
  • Cytokinetics (CYTK) Q2 2026 earnings call

    Management framed the quarter as accelerating U.S. launch execution, broadening prescriber adoption, and advancing aficamten toward NHCM filing.

    Aug 06, 2026Confident0.86
  • Dragonfly Energy Holdings (DFLI) Q2 2026 earnings call

    Management framed trucking scale-up and Dakota integration as the near-term path toward profitability despite prolonged RV weakness.

    Aug 06, 2026Positive0.55
  • Denali Therapeutics (DNLI) Q2 2026 earnings call

    Management framed the quarter as early commercial validation of the transport-vehicle platform, with launch momentum supporting broader pipeline execution.

    Aug 06, 2026Confident0.82

Companies covered

1,674 companies

158 more under A